Caravel Oculus
NEWS
2026-07-17
NEWS
Caravel Oculus Advances Novel Corneal Drug CA201A Globally with Phase II Trial Recruitment in Australia
2025-06-05
EVENT
Our company convened the 2025 annual shareholders’ meeting on June 5
2025-02-27
EVENT
Our company convened the first extraordinary shareholders’ meeting on February 27
2025-02-27
EVENT
Caravel Oculus Inc. held the opening party in Taipei office